Literature DB >> 34050442

Determination of VEGF165 using impedimetric aptasensor based on cyclohexanehexone-melem covalent-organic framework.

Jiangnan Li1, Yang Liu1, Changbao Wang2, Qiaojuan Jia2, Geyi Zhang1, Xiaoyu Huang1, Nan Zhou3, Zhihong Zhang4.   

Abstract

A porous nanostructured covalent-organic framework (COF) has been prepared via condensation polymerization between the two building blocks of melem and hexaketocyclohexane octahydrate (represented as M-HO-COF). Basic characterizations revealed that the M-HO-COF network was composed of C=N and highly conjugated aromatic moieties, along with a high surface area, large pore size, remarkable electrochemical activity, and strong bioaffinity toward aptamer strands. Given that the vascular endothelial growth factor 165 (VEGF165)-targeted aptamer was stably anchored over M-HO-COF via weak intermolecular forces, the prepared M-HO-COF network exhibited great potential as a sensitive and selective platform for the impedimetric VEGF165 aptasensor. Consequently, the M-HO-COF-based aptasensor displayed an ultralow limit of detection of 0.18 fg mL-1 within a wide range of VEGF165 concentrations from 1 fg mL-1 to 10 ng mL-1. Considering its strong fluorescence performance, excellent biocompatibility, and small nanosheet-like structure, the obtained COF-based aptasensor showed a superior sensing performance and regeneration capability after 7 regeneration cycles for the detection of osteosarcoma cells (K7M2 cells), which overexpressed with VEGF165, with a low limit of detection of 49 cells mL-1. For real f human serum samples, the obtained COF-based aptasensor exhibits acceptable mean apparent recoveries of 97.41% with a relative standard deviation of 4.60%. Furthermore, the proposed bifunctional aptasensor for the detection VEGF165 and K7M2 cells exhibited good stability, appropriate selectivity toward other biomarkers or normal cells, acceptable reproducibility, and applicability. A bifunctional sensing system was constructed for detecting osteosarcoma cells (K7M2 cells) and VEGF165 based on the a porous nanostructured covalent-organic framework (M-HO-COF) via condensation polymerization between melem and hexaketocyclohexane octahydrate. The M-HO-COF-based aptasensor displayed ultralow detection limit of 0.18 fg mL-1 toward VEGF165 and 49 cell mL-1 for K7M2 cells with high selectivity, acceptable reproducibility, and good stability.

Entities:  

Keywords:  Cancer biomarkers; Covalent-organic framework; Early diagnosis; Impedimetric aptasensor; Melem and hexaketocyclohexane octahydrate

Mesh:

Substances:

Year:  2021        PMID: 34050442     DOI: 10.1007/s00604-021-04843-9

Source DB:  PubMed          Journal:  Mikrochim Acta        ISSN: 0026-3672            Impact factor:   5.833


  25 in total

Review 1.  Aptamer-based biosensors and nanosensors for the detection of vascular endothelial growth factor (VEGF): A review.

Authors:  Sadegh Dehghani; Rahim Nosrati; Meysam Yousefi; Alireza Nezami; Fatemeh Soltani; Seyed Mohammad Taghdisi; Khalil Abnous; Mona Alibolandi; Mohammad Ramezani
Journal:  Biosens Bioelectron       Date:  2018-03-19       Impact factor: 10.618

2.  High serum vascular endothelial growth factor levels predict poor prognosis after radiofrequency ablation of hepatocellular carcinoma: importance of tumor biomarker in ablative therapies.

Authors:  Ronnie T P Poon; Cecilia Lau; Roberta Pang; Kelvin K Ng; Jimmy Yuen; Sheung Tat Fan
Journal:  Ann Surg Oncol       Date:  2007-04-04       Impact factor: 5.344

Review 3.  Role of the vascular endothelial growth factor pathway in tumor growth and angiogenesis.

Authors:  Daniel J Hicklin; Lee M Ellis
Journal:  J Clin Oncol       Date:  2004-12-07       Impact factor: 44.544

4.  Associations of vascular endothelial growth factor (VEGF) with adhesion and inflammation molecules in a healthy population.

Authors:  Mohsen Azimi-Nezhad; Maria G Stathopoulou; Amélie Bonnefond; Marc Rancier; Abdelsalam Saleh; John Lamont; Peter Fitzgerald; Ndeye Coumba Ndiaye; Sophie Visvikis-Siest
Journal:  Cytokine       Date:  2012-11-30       Impact factor: 3.861

Review 5.  A review of clinical and molecular prognostic factors in osteosarcoma.

Authors:  Jonathan C M Clark; Crispin R Dass; Peter F M Choong
Journal:  J Cancer Res Clin Oncol       Date:  2007-10-27       Impact factor: 4.553

6.  International osteosarcoma incidence patterns in children and adolescents, middle ages and elderly persons.

Authors:  Lisa Mirabello; Rebecca J Troisi; Sharon A Savage
Journal:  Int J Cancer       Date:  2009-07-01       Impact factor: 7.396

Review 7.  Osteosarcoma: a review of current and future therapeutic approaches.

Authors:  Xin Zhao; Qirui Wu; Xiuqing Gong; Jinfeng Liu; Yujie Ma
Journal:  Biomed Eng Online       Date:  2021-03-02       Impact factor: 2.819

8.  VEGF 165 b, an antiangiogenic VEGF-A isoform, binds and inhibits bevacizumab treatment in experimental colorectal carcinoma: balance of pro- and antiangiogenic VEGF-A isoforms has implications for therapy.

Authors:  A H R Varey; E S Rennel; Y Qiu; H S Bevan; R M Perrin; S Raffy; A R Dixon; C Paraskeva; O Zaccheo; A B Hassan; S J Harper; D O Bates
Journal:  Br J Cancer       Date:  2008-03-18       Impact factor: 7.640

Review 9.  Electrochemical Sensors Based on Covalent Organic Frameworks: A Critical Review.

Authors:  Sidi Chen; Baiqing Yuan; Gang Liu; Daojun Zhang
Journal:  Front Chem       Date:  2020-11-26       Impact factor: 5.221

10.  High VEGF with rapid growth and early metastasis in a mouse osteosarcoma model.

Authors:  Shang-You Yang; Haiying Yu; Jeffrey E Krygier; Paul H Wooley; Michael P Mott
Journal:  Sarcoma       Date:  2007
View more
  1 in total

Review 1.  Electrochemical (Bio)Sensors Based on Covalent Organic Frameworks (COFs).

Authors:  Emiliano Martínez-Periñán; Marcos Martínez-Fernández; José L Segura; Encarnación Lorenzo
Journal:  Sensors (Basel)       Date:  2022-06-23       Impact factor: 3.847

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.